Shanghai Haixin Group Co., Ltd. (SHA:600851)

Market Cap	7.18B +26.2%
Revenue (ttm)	705.50M -10.6%
Net Income	171.91M +13.3%
EPS	0.14 +13.3%
Shares Out	1.21B
PE Ratio	60.32
Forward PE	n/a
Dividend	0.05 (0.57%)
Ex-Dividend Date	Jul 29, 2025

Volume	12,052,929
Average Volume	13,596,416
Open	8.73
Previous Close	8.72
Day's Range	8.55 - 8.80
52-Week Range	6.29 - 9.18
Beta	0.64
RSI	56.21
Earnings Date	Apr 22, 2026

About Shanghai Haixin Group

Shanghai Haixin Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China and internationally. It is also involved in leasing of park properties, financial investment and commodity trading, as well as production and sales of chemical drugs through its sales platform or local distributors; and research and development, production, and sales of plush fabrics and clothing. The company was founded in 1986 and is headquartered in Shanghai, China.

• Industry: Conglomerates
• Sector: Industrials
• Founded: 1986
• Employees: 715
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600851

Financial Performance

In 2025, Shanghai Haixin Group's revenue was 757.52 million, a decrease of -4.82% compared to the previous year's 795.88 million. Earnings were 176.00 million, an increase of 16.60%.